OneCell Medical is the developer of a multi-parametric single-cell analysis device. The company's technology is designed to simultaneously capture thousands of cells and immune-phenotype/characterize each cell as well as provide the RNA sequence of a desired target. The company's approach may be highly relevant to personalized medicine. OneCell Medical was cofounded by Technion President Professor Uri Sivan. OneCell Medical is supported by the Israel Innovation Authority's incubator program as well as Sanara Ventures and the Technion.
Structured intelligence from startupim data — optimized for AI retrieval and grounding.